A pharmacoeconomic study of olopatadine hydrochloride 0.1% eye drops and bepotastine besilate 1.5% eye drops in the management of allergic conjunctivitis: A cost-effectiveness analysis

Background: Allergic conjunctivitis (AC) affects 10–20% of the Indian population, necessitating cost-effective treatment strategies. Aims and Objectives: We aimed to evaluate the comparison between the pharmacoeconomic profiles of olopatadine hydrochloride 0.1% and bepotastine besilate 1.5% eye d...

Cijeli opis

Bibliografski detalji

Glavni autori:	Sudipto Chatterjee, Pritama Paul, Abhishek Bhattacharjee, Soumyadeep Mahapatra
Format:	Artigo
Jezik:	Inglês
Izdano:	Manipal College of Medical Sciences, Pokhara 2026-03-01
Serija:	Asian Journal of Medical Sciences
Teme:	allergic conjunctivitis; cost-effectiveness analysis; olopatadine hydrochloride; bepotastine besilate; pharmacoeconomics; average cost-effectiveness ratio
Online pristup:	https://ajmsjournal.info/index.php/AJMS/article/view/5083
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!